RPTP Key Stats
- RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Finan Yahoo 02/26 16:39 ET
- RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Other Events Yahoo 02/24 13:26 ET
- Why puts are bullish on Raptor Yahoo 02/24 10:39 ET
- Raptor Pharmaceutical to Present at Two Upcoming Investor Conferences noodls 02/24 08:38 ET
- Raptor Soars on Positive RP103 Data Yahoo 02/21 15:30 ET
- Raptor Soars on Positive RP103 Data - Analyst Blog Zacks 02/21 10:30 ET
- Pre-Open Stock Movers 2/21: (ESC) (MVIS) (COMM) Higher; (FLTX) (GRPN) (ANAD) Lower (more...) Street Insider 02/21 09:32 ET
- Ladenburg Thalmann Downgrades Raptor Pharmaceuticals (RPTP) to Neutral Street Insider 02/21 07:08 ET
- Biotech Stock Mailbag: Raptor, Chelsea, Oncogenex, More Hate Mail! The Street 02/21 01:00 ET
- Why Raptor Pharmaceuticals Corp. Shares Clawed Higher Yahoo 02/20 15:17 ET
RPTP Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Raptor Pharmaceutical is up 194.9% over the last year vs S&P 500 Total Return up 24.54%, AstraZeneca up 52.84%, and Jazz Pharmaceuticals up 158.2%.
Balance Sheet View Statement
Pro Ratings for RPTP
Pro Report PDF for RPTP
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download RPTP Pro Report PDF
Pro Strategies Featuring RPTP
Did Raptor Pharmaceutical make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Headquarters Country: United States
- Headquarters State/Province: California
- Incorporation Country: United States
- Incorporation State/Province: Delaware
Raptor Pharmaceutical Corp is a biopharmaceutical company that researches, produces and delivers medicines. Its pipeline includes both candidates from its proprietary drug targeting platforms and in-licensed and acquired product candidates.